February 10, 2023
Kyowa Kirin President & CEO Masashi Miyamoto Kyowa Kirin has no intention for now of launching a biological authorized generic (AG), or “biosame,” of its neutropenia drug G-Lasta (pegfilgrastim), which is expected to soon face biosimilar entries in Japan, President...read more